What is the risk of uterine rupture in women undergoing a trial of labor after cesarean (TOLAC) when oxytocin is used for labor augmentation?
Fuente:
Zenodo
Salvato in:
| Autore principale: | |
|---|---|
| Natura: | Recurso digital |
| Pubblicazione: |
Zenodo
2025
|
| Soggetti: | |
| Accesso online: | |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
| _version_ | 1866901334474620928 |
|---|---|
| author | Tripdatabase |
| author_facet | Tripdatabase |
| contents | Using oxytocin during a trial of labor after cesarean is associated with a higher risk of uterine rupture compared to spontaneous labor without augmentation. |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_17904714 |
| institution | Zenodo |
| language | |
| publishDate | 2025 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | What is the risk of uterine rupture in women undergoing a trial of labor after cesarean (TOLAC) when oxytocin is used for labor augmentation? Tripdatabase risk uterine rupture women undergoing trial labor after cesarean tolac when oxytocin used augmentation Using oxytocin during a trial of labor after cesarean is associated with a higher risk of uterine rupture compared to spontaneous labor without augmentation. |
| title | What is the risk of uterine rupture in women undergoing a trial of labor after cesarean (TOLAC) when oxytocin is used for labor augmentation? |
| topic | risk uterine rupture women undergoing trial labor after cesarean tolac when oxytocin used augmentation |
| url | https://doi.org/10.5281/zenodo.17904714 |